FindTrial
Sign In

Measure of Depression and Anxiety level in Home Isolated Covid positive patients

Evaluation of Depression and Anxiety in home quarantined Covid positive patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/031662
Enrollment
200
Registered
2021-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases

Interventions

None listed

Sponsors

Smt NHL Municipal Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consenting home quarantined COVID positive patients .

Exclusion criteria

Exclusion criteria: Patients who are not willing to participate in the study. Patients already having Past H/O psychiatric illness.

Design outcomes

Primary

MeasureTime frame
Level of Depression and Anxiety in home quarantined positive patientsTimepoint: Within 14 days of home quarantine period after patient is diagnosed as Covid positive—

Secondary

MeasureTime frame
Morbididty (Depression and Anxiety Level) in Covid positive home quarantined patientsTimepoint: Within 14 days of home quarantined period after patient is diagnosed as Covid 19 positive—

Countries

India

Contacts

Public ContactDr Heena Jariwala

SVPIMSR, Smt. NHL MMC

itisnilima@gmail.com9328670900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026